Table 1 Characteristics of the study participants in the CHARLS study according to age group
From: Determinants of COVID-19 vaccination status and hesitancy among older adults in China
Characteristic | Total sample n = 12,900 | 52–59 n = 3,536 | 60–69 n = 4,587 | 70–79 n = 3,578 | ≥80 n = 1,199 |
|---|---|---|---|---|---|
Sex | |||||
Female | 6,858 (53.2%) | 1,919 (54.3%) | 2,429 (53.0%) | 1,858 (51.9%) | 652 (54.4%) |
Male | 6,042 (46.8%) | 1,617 (45.7%) | 2,158 (47.0%) | 1,720 (48.1%) | 547 (45.6%) |
Marital status | |||||
Married | 10,635 (82.6%) | 3,290 (93.2%) | 4,047 (88.4%) | 2,701 (75.5%) | 597 (49.9%) |
Unmarried or widowed | 2,245 (17.4%) | 241 (6.8%) | 529 (11.6%) | 875 (24.5%) | 600 (50.1%) |
Vaccination status | |||||
Unvaccinated | 791 (6.1%) | 130 (3.7%) | 199 (4.3%) | 247 (6.9%) | 215 (17.9%) |
Only one dose | 337 (2.6%) | 43 (1.2%) | 85 (1.9%) | 115 (3.2%) | 94 (7.8%) |
Primary series completed | 1,805 (14.0%) | 379 (10.7%) | 587 (12.8%) | 560 (15.7%) | 279 (23.3%) |
Booster | 9,967 (77.3%) | 2,984 (84.4%) | 3,716 (81.0%) | 2,656 (74.2%) | 611 (51.0%) |
Ethnicity | |||||
Han | 11,929 (93.0%) | 3,231 (92.1%) | 4,230 (93.0%) | 3,342 (93.7%) | 1,126 (94.1%) |
Non-Han (minority) | 892 (7.0%) | 276 (7.9%) | 320 (7.0%) | 225 (6.3%) | 71 (5.9%) |
Education | |||||
Illiterate | 3,716 (28.8%) | 539 (15.2%) | 1,310 (28.6%) | 1,291 (36.1%) | 576 (48.0%) |
Primary (includes literate) | 4,899 (38.0%) | 1,392 (39.4%) | 1,456 (31.7%) | 1,621 (45.3%) | 430 (35.9%) |
Middle and high school or higher | 4,281 (33.2%) | 1,604 (45.4%) | 1,820 (39.7%) | 664 (18.6%) | 193 (16.1%) |
Residence (Hukou) | |||||
Rural residence | 10,500 (81.4%) | 2,963 (83.8%) | 3,773 (82.3%) | 2,841 (79.4%) | 923 (77.0%) |
Urban residence | 2,398 (18.6%) | 572 (16.2%) | 814 (17.7%) | 736 (20.6%) | 276 (23.0%) |
Region | |||||
East | 4,448 (34.5%) | 1,215 (34.4%) | 1,705 (37.2%) | 1,116 (31.2%) | 412 (34.4%) |
Central | 3,836 (29.7%) | 1,034 (29.2%) | 1,301 (28.4%) | 1,134 (31.7%) | 367 (30.6%) |
West | 3,719 (28.8%) | 1,050 (29.7%) | 1,218 (26.6%) | 1,096 (30.6%) | 355 (29.6%) |
Northeast | 897 (7.0%) | 237 (6.7%) | 363 (7.9%) | 232 (6.5%) | 65 (5.4%) |
Functional dependency | 1,699 (13.2%) | 226 (6.4%) | 464 (10.2%) | 601 (16.8%) | 408 (34.2%) |
Chronic conditions | |||||
Hypertension | 5,773 (44.9%) | 1,198 (34.0%) | 2,013 (44.0%) | 1,937 (54.2%) | 625 (52.4%) |
Heart disease | 2,814 (21.9%) | 522 (14.8%) | 979 (21.4%) | 999 (28.0%) | 314 (26.3%) |
Stroke | 809 (6.3%) | 122 (3.5%) | 248 (5.4%) | 329 (9.2%) | 110 (9.2%) |
Diabetes | 1,980 (15.4%) | 442 (12.5%) | 757 (16.6%) | 629 (17.6%) | 152 (12.8%) |
Lung disease | 1,975 (15.4%) | 381 (10.8%) | 684 (15.0%) | 671 (18.8%) | 239 (20.1%) |
Cancer | 331 (2.6%) | 78 (2.2%) | 127 (2.8%) | 105 (2.9%) | 21 (1.8%) |
Dyslipidemia | 3,428 (26.7%) | 865 (24.5%) | 1,270 (27.8%) | 1,051 (29.4%) | 242 (20.3%) |
Liver disease | 862 (6.7%) | 224 (6.4%) | 319 (7.0%) | 260 (7.3%) | 59 (4.9%) |
Kidney disease | 1,128 (8.8%) | 238 (6.8%) | 409 (8.9%) | 371 (10.4%) | 110 (9.2%) |
Asthma | 789 (6.1%) | 116 (3.3%) | 276 (6.0%) | 302 (8.5%) | 95 (8.0%) |
Arthritis/rheumatism | 4,817 (37.5%) | 1,126 (31.9%) | 1,745 (38.2%) | 1,499 (42.0%) | 447 (37.5%) |
Digestive disease | 3,718 (28.9%) | 1,038 (29.4%) | 1,339 (29.3%) | 1,042 (29.2%) | 299 (25.1%) |
